Melinta Therapeutics Inc. buy Quitte
Start price
18.09.18
/
50%
€19.28
Target price
18.09.18
€23.45
Performance (%)
0.00%
End price
18.09.18
€19.28
Summary
This prediction ended on 18.09.18 with a price of €19.28. Quitte's BUY prediction for Melinta Therapeutics Inc. closed unchanged from the start price. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % | 44,54 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % | 80,99 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % | 45,26 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % | 61,12 % |
Comments by Quitte for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
Nachholpotenzial
https://www.streetinsider.com/Corporate+News//Melinta+Therapeutics+%28MLNT%29+Names+Peter+Milligan+as+CFO/14617554.html
Stopped prediction by Quitte for Melinta Therapeutics Inc.
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.44
06.01.20
06.01.20
-
09.01.20
09.01.20
1.35%
09.01.20
09.01.20
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.14
07.01.19
07.01.19
€13.53
08.07.19
08.07.19
25.78%
08.07.19
08.07.19
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.98
29.10.18
29.10.18
€22.55
07.01.19
07.01.19
-53.18%
07.01.19
07.01.19
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.73
18.09.18
18.09.18
€31.57
29.10.18
29.10.18
-42.40%
29.10.18
29.10.18
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.48
30.12.16
30.12.16
€95.00
28.03.17
28.03.17
52.77%
28.03.17
28.03.17